Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Example of Drug Shortage Information and Links
National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information: (updated October 24, 2025)
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| dronabinol oral capsules | Supply is critical. Est. release: Oct 2025 |
| erythromycin injectable | Supply is nearly depleted. Est. release: FEb 2026 |
| Factor VIII (Recombinate®) | Supply is depleted. Recombinate® is discontinued |
| lorazepam injectable | Supply is critical. Est. release: Nov 2025 |
| meperidine injectable | Supply is critical. Est. release: Nov 2025 |
| methylprednisolone 2 mg tablets | Supply is depleted. Estimated release: Jan 2026 |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| alteplase 100 mg vials | Supply is limited. Est. release: None |
| pancrelipase (Viokace® 20,880) | Supply is critical. Est. release: Nov 2025 |
| penicillin G benzathine | Supply is limited. Est release Nov 2025 |
| sodium bicarbonate 8.4% injectable | 10 mL syringes are discontinued. 10 mL vials are depleted. Est. release: Oct 2025 (50 mL vials and syringes are unaffected) |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| acetazolamide 500 mg injectable | Supply is adequate to meet needs. |
| megestrol 40 mg tablets | Supply is adequate to meed needs. |
| promethazine injectable | Supply is adequate to meed needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| lindane products | All presentations have been discontinued FDA Orange Book |
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |